Synovial White Blood Cell Count and Differential to Predict Successful Infection Management in a Two-Stage Revision

Background: An array of synovial white blood cell (WBC) count and polymorphonuclear differential (PMN%) thresholds have been reported using 2013 Musculoskeletal Infection Society (MSIS) definition which has a poor accuracy to confirm infection control before reimplantation. The workgroup of MSIS recently developed a comprehensive definition of successful infection management. Our objectives were to determine optimal thresholds for WBC count and PMN% associated with reimplantation success based on this new MSIS definition and assess if values above these thresholds indicate decreased survival time. Methods: A retrospective review was conducted on a consecutive series of 133 two-stage hip/knee arthroplasties performed by 15 surgeons (2014-2020) at 2 institutions. All surgeries had a minimum follow-up of 1 year. The inclusion criteria included reporting of preoperative synovial fluid aspiration results. Thus, 88 were finally included. Surgical success was defined by MSIS outcome reporting tool (Tiers 1-4). Receiver operating characteristic curve analyses were performed to estimate optimal thresholds of WBC count and PMN%. A Kaplan-Meier survival analyses with log-rank test were performed. Results: With area under the curve of 0.65, synovial PMN% showed superior accuracy than WBC count (area under the curve = 0.52) in determining outcome of reimplantation. The optimal PMN% threshold (62%) demonstrated sensitivity of 57% and specificity of 77%. The calculated WBC count threshold (2,733/ mL) showed poor sensitivity (21%) but high specificity (95%). There was a significant difference in failure free survival (24 months) between the cases with WBC count higher vs lower than 2,733/mL (P = .002). This was also true for PMN% at 5 months postoperatively (P = .009). Conclusion: WBC count (2,733/mL) shows very high specificity to confirm successful reimplantation. Both WBC count and PMN% (62%) thresholds can significantly determine reimplantation survival. (c) 2022 Elsevier Inc. All rights reserved.